There is basically no research that looks at the impact of antidepressants on emerging sexuality. Here are the key things we ...

One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, ...

The FDA approved a drug made by Kura Oncology to treat patients with a certain type of genetically altered leukemia.

A new malaria drug, Ganaplacide/Lumefantrine, shows over 97% cure rates in trials. This treatment is effective even where ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

A strategic and financial recalibration on psychiatric drug development brings profound implications for investors, insurers, ...

This article addresses the high failure rates in drug development, offering insights on improving clinical trials through AI ...

OneSource Specialty Pharma has raised its FY28 revenue forecast from $400 million to over $500 million, driven by strong ...

India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease ...

Dr. Richard Pazdur, who has been the F.D.A.’s top cancer drug regulator, represents a stabilizing choice for an agency ...

Denmark's Zealand Pharma said on Thursday it has paused the development of an early-stage obesity drug candidate as it shifts focus to more promising programs.

Pfizer noted it has completed its acquisition of all outstanding shares of the company’s common stock for $65.60 per share in ...